A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution Compared to DF289 Otic Solution and to DF277 Otic Solution in the Treatment of Acute Otitis Externa (AOE)
Phase of Trial: Phase III
Latest Information Update: 25 Sep 2018
At a glance
- Drugs Ciprofloxacin/fluocinolone acetonide (Primary) ; Ciprofloxacin; Fluocinolone acetonide
- Indications Otitis externa
- Focus Therapeutic Use
- Sponsors SALVAT
- 25 Sep 2018 Planned End Date changed from 1 Aug 2018 to 1 Sep 2018.
- 25 Jul 2018 Planned End Date changed from 1 Dec 2017 to 1 Aug 2018.
- 25 Jul 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.